LMNTS

Latest SEC Filings & News for LMNTS

2 most recent filings and news items mentioning LMNTS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/LMNTS/news?limit=20"

Pull LMNTS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
OfferingJun 3, 2026Positive

Liminatus Pharma issues common stock purchase warrants under Securities Act exemption

Liminatus Pharma filed a warrant agreement allowing holders to purchase common stock at a specified exercise price through 2031. The unregistered securities offering provides capital formation flexibility for the pharmaceutical company.

View filing at SEC.gov →
M&AMay 20, 2026Positive

Liminatus Pharma to acquire InnocsAI LLC in merger agreement dated May 17, 2026

Liminatus Pharma, Inc. has entered into a merger agreement to acquire InnocsAI LLC, a Delaware limited liability company. The transaction represents a significant corporate combination for the pharmaceutical company.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.